Mouse IL-2(Interleukin 2) ELISA Kit
中文名称:小鼠白介素2(IL-2)酶联免疫吸附测定试剂盒
别称:
IL2、TCGF、Lymphokine
Price:
Size:
96T
48T
96T*5
- 反应性: Mouse
- 检测范围: 15.63-1000 pg/mL
- 灵敏度: 9.38 pg/mL
产品应用 | ELISA |
检测原理 | 本试剂盒采用双抗体夹心ELISA法。用抗小鼠IL-2抗体包被于酶标板上,实验时样品(或标准品)中的小鼠IL-2会与包被抗体结合。后依次加入生物素化的抗小鼠IL-2抗体和辣根过氧化物酶标记的亲和素,抗小鼠IL-2抗体与结合在包被抗体上的小鼠IL-2结合,生物素与亲和素特异性结合而形成免疫复合物,游离的成分被洗去。加入显色底物(TMB),TMB在辣根过氧化物酶的催化下呈现蓝色,加终止液后变成黄色。用酶标仪在450 nm波长处测OD值,IL-2浓度与OD450值之间呈正比,通过绘制标准曲线计算出样品中IL-2的浓度。 |
反应类型 | Sandwich-ELISA |
规格 |
96T
/ 48T
/ 96T*5
|
反应时间 | 3.5h |
反应性 | Mouse |
检测方法 | Colormetric |
检测范围 | 15.63-1000 pg/mL |
灵敏度 | 9.38 pg/mL |
样本体积 | 100μL |
样本类型 | 血清、血浆或其他生物体液 |
特异性 | 可检测样本中的小鼠IL-2,且与其它类似物无明显交叉反应 |
精密度 | 板内,板间变异系数均<10% |
回收率 | 80%-120% |
储存条件 | 2-8℃/-20℃ |
数据处理 |
-
Combination of metabolic intervention and T cell therapy enhances solid tumor immunotherapy
IF: 16.304 -
Highly tailorable gellan gum nanoparticles as a platform for the development of T cell activator systems
IF: 15.863 -
Glucocorticoid-induced loss of beneficial gut bacterial extracellular vesicles is associated with the pathogenesis of osteonecrosis
IF: 14.957Journal:Science Advances -
Treg-targeted efficient-inducible platform for collagen-induced arthritis treatment
IF: 10.761Journal:Materials Today Bio -
Dissolvable microneedles based on Panax notoginseng polysaccharide for transdermal drug delivery and skin dendritic cell activation
IF: 9.381 -
Structural characterization of a soluble polysaccharide SSPS1 from soy whey and its immunoregulatory activity in macrophages
IF: 8.025Journal:INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULESPMID:35835298 -
Aronia melanocarpa Extract Fermented by Lactobacillus plantarum EJ2014 Modulates Immune Response in Mice
IF: 6.313 -
Erianin inhibits human lung cancer cell growth via PI3K/Akt/mTOR pathway in vitro and in vivo
IF: 5.882 -
A different approach to immunochemotherapy for colon Cancer: Development of nanoplexes of cyclodextrins and Interleukin-2 loaded with 5-FU
IF: 5.875 -
Immunomodulatory effects and mechanisms of Tiepishihu Xiyangshen granules on cyclophosphamide induced immuno-suppression via TLR4/MAPKs and PI3K/AKT/FOXO3a signal pathways
IF: 5.195Journal:JOURNAL OF ETHNOPHARMACOLOGY